Drug: REBETOL Injury: Hyperbilirubinaemia Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
115151109 | REBETOL | Hyperbilirubinaemia | GILEAD | 67.00 YR | F | 156 KG | 20160909 | JP |
124619763 | REBETOL | Hyperbilirubinaemia | MERCK | 0.00 | M | 0 | 20160802 | US |
125412412 | REBETOL | Hyperbilirubinaemia | MERCK | 70.00 YR | M | 0 | 20160722 | JP |
125506442 | REBETOL | Hyperbilirubinaemia | ABBVIE | 73.65 YR | F | 0 | 20160805 | COUNTRY NOT SPECIFIED |
126416181 | REBETOL | Hyperbilirubinaemia | ABBVIE | 61.56 YR | F | 0 | 20160810 | COUNTRY NOT SPECIFIED |
126626571 | REBETOL | Hyperbilirubinaemia | MERCK | 44.00 YR | M | 0 | 20160818 | JP |
Total Records: 6 Number of Pages: 1